Literature DB >> 11513099

Route learning performance in Alzheimer disease patients.

M M Cherrier1, M Mendez, K Perryman.   

Abstract

OBJECTIVE: To examine performance on an objective measure of route learning in Alzheimer disease (AD) patients.
BACKGROUND: Topographic disorientation (TD) is a common problem among AD patients. The underlying cognitive deficits that contribute to TD in AD patients are not well understood.
METHOD: This study examined 19 healthy older individuals (controls) and 16 AD patients who were administered a comprehensive neuropsychological battery along with a novel Route Learning Test (RLT). Areas assessed included incidental learning, spatial relations. recall of the walking route, and recognition of landmarks.
RESULTS: Despite comparable performance on basic visuospatial ability measures, AD patients performed significantly worse than controls on the RLT and evidenced poor incidental learning for environmental details. A measure of egocentric and allocentric orientation ability was the best predictor of RLT performance in AD patients. Among RLT subtests, AD patients performed best on recognition of landmarks compared with recognition and recall of spatial layout or recognition of incidental items in the environment.
CONCLUSIONS: Our findings suggest that poor performance on the RLT in AD patients is characteristic of poor spatial orientation or spatial reasoning. Therefore, episodes of TD in AD patients may occur secondary to poor spatial orientation.

Entities:  

Mesh:

Year:  2001        PMID: 11513099

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  25 in total

1.  Driver landmark and traffic sign identification in early Alzheimer's disease.

Authors:  E Y Uc; M Rizzo; S W Anderson; Q Shi; J D Dawson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

2.  Salient Cues and Wayfinding in Alzheimer's Disease within a Virtual Senior Residence.

Authors:  Rebecca Davis; Jennifer M Ohman; Catherine Weisbeck
Journal:  Environ Behav       Date:  2016-11-22

3.  Spatial Navigation in Preclinical Alzheimer's Disease.

Authors:  Samantha L Allison; Anne M Fagan; John C Morris; Denise Head
Journal:  J Alzheimers Dis       Date:  2016-02-09       Impact factor: 4.472

Review 4.  Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.

Authors:  Jessica L Hoffman; Sara Faccidomo; Michelle Kim; Seth M Taylor; Abigail E Agoglia; Ashley M May; Evan N Smith; L C Wong; Clyde W Hodge
Journal:  Int Rev Neurobiol       Date:  2019-10-23       Impact factor: 3.230

Review 5.  Where am I and how will I get there from here? A role for posterior parietal cortex in the integration of spatial information and route planning.

Authors:  Jeffrey L Calton; Jeffrey S Taube
Journal:  Neurobiol Learn Mem       Date:  2008-11-12       Impact factor: 2.877

6.  Creating a Supportive Environment Using Cues for Wayfinding in Dementia.

Authors:  Rebecca Davis; Catherine Weisbeck
Journal:  J Gerontol Nurs       Date:  2016-03       Impact factor: 1.254

7.  Spatial navigation deficit in amnestic mild cognitive impairment.

Authors:  Jakub Hort; Jan Laczó; Martin Vyhnálek; Martin Bojar; Jan Bures; Kamil Vlcek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

8.  Egocentric and exocentric navigation skills in older adults.

Authors:  Amy E Sanders; Roee Holtzer; Richard B Lipton; Charles Hall; Joe Verghese
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-12       Impact factor: 6.053

9.  Eye Tracking Analysis of Visual Cues during Wayfinding in Early Stage Alzheimer's Disease.

Authors:  Rebecca Davis; Alla Sikorskii
Journal:  Dement Geriatr Cogn Disord       Date:  2020-06-09       Impact factor: 2.959

10.  Landmark recognition in Alzheimer's dementia: spared implicit memory for objects relevant for navigation.

Authors:  Roy P C Kessels; Amy van Doormaal; Gabriele Janzen
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.